Comparison of available treatments for tobacco addiction.

Current Psychiatry Reports
Aryeh I Herman, Mehmet Sofuoglu

Abstract

Cigarette smoking is a major public health problem that causes more than 5 million deaths annually worldwide. Cigarette smoking is especially common among individuals with psychiatric comorbidity, including individuals with primary psychiatric disorders and other addictions. Effective behavioral and pharmacologic treatments for smoking cessation are available. Behavioral treatments including brief (< 3 min) counseling by physicians are effective. Seven first-line pharmacologic treatments are currently available: five nicotine replacement therapies, bupropion, and varenicline. In addition, clonidine and nortriptyline are second-line treatments for smoking cessation. These treatments increase the chances of quitting smoking by two- to threefold, supporting their use in smokers who are motivated to quit. However, effective treatments for many subpopulations, including smokers with psychiatric comorbidities as well as adolescent, pregnant, or postpartum smokers, remain to be developed and represent an important challenge.

References

Dec 1, 1993·Clinical Pharmacology and Therapeutics·A H GlassmanT B Cooper
Mar 10, 1993·JAMA : the Journal of the American Medical Association·P TønnesenF Nilsson
Aug 26, 1998·Archives of General Psychiatry·S M HallE Triffleman
Oct 20, 1998·Archives of Internal Medicine·A V ProchazkaD Lofaso
Mar 4, 2000·The American Journal of Psychiatry·J Y TsohS M Hall
Mar 22, 2002·Neuron·Huibert D MansvelderDaniel S McGehee
Nov 19, 2002·Journal of Neurobiology·Michael W Quick, Robin A J Lester
Jan 30, 2003·American Journal of Preventive Medicine·Gregory J Colman, Ted Joyce
Aug 13, 2003·Mayo Clinic Proceedings·J Taylor Hays, Jon O Ebbert
Oct 28, 2003·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Jae H ChoiKenneth R Strahs
Dec 3, 2003·Psychopharmacology·Vyga KaufmannCaryn Lerman
Dec 23, 2003·Journal of General Internal Medicine·John R Hughes
Jul 22, 2004·The Cochrane Database of Systematic Reviews·S G GourlayN L Benowitz
Dec 23, 2004·Journal of Consulting and Clinical Psychology·Judith J ProchaskaSharon M Hall
Nov 22, 2005·Expert Opinion on Drug Delivery·Saul ShiffmanJack E Henningfield
Jul 13, 2006·Expert Review of Neurotherapeutics·Marc E Mooney, Mehmet Sofuoglu
Oct 3, 2006·Annual Review of Pharmacology and Toxicology·John A Dani, Daniel Bertrand
Oct 4, 2006·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·Steve SussmanClyde W Dent
Jan 27, 2007·The Cochrane Database of Systematic Reviews·J R HughesT Lancaster
Feb 22, 2007·PloS One·Bernard Le FollSteven R Goldberg
May 31, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mehmet SofuogluMarc Mooney
Jun 30, 2007·American Journal of Public Health·Judith J ProchaskaJulie A Gorecki
Jul 10, 2008·The American Journal on Addictions·Marc E MooneyMehmet Sofuoglu
Jul 12, 2008·American Journal of Preventive Medicine·UNKNOWN Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff
Dec 26, 2008·European Heart Journal·Salvatore MottilloMark J Eisenberg
Feb 3, 2009·Handbook of Experimental Pharmacology·David J K Balfour
Mar 31, 2009·Annual Review of Clinical Psychology·Sharon M Hall, Judith J Prochaska
May 14, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Elyse R ParkNancy Rigotti
Jun 6, 2009·Therapeutic Advances in Cardiovascular Disease·William H Frishman
Aug 12, 2009·BMC Public Health·David LawrenceStephen R Zubrick
Sep 1, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Cheryl A Oncken, H R Kranzler
Nov 4, 2009·Archives of General Psychiatry·Megan E PiperTimothy B Baker
Aug 19, 2010·The American Journal on Addictions·James PolingMehmet Sofuoglu
Nov 3, 2010·The American Journal of Medicine·Sripal BangaloreFranz H Messerli

❮ Previous
Next ❯

Citations

May 11, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Svetlana SemenovaAthina Markou
Apr 11, 2013·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Paolo MannelliDavid A Gorelick
Feb 6, 2014·Multidisciplinary Respiratory Medicine·Elif Yilmazel UcarLeyla Saglam
Jul 9, 2013·Indian Journal of Psychological Medicine·Aditya HegdeSiddharth Sarkar
Jan 22, 2014·Pharmacogenomics·Aryeh I HermanMehmet Sofuoglu
Aug 27, 2014·Mental Health and Physical Activity·Joseph T CiccoloMerle Myerson
Jun 4, 2011·Expert Opinion on Drug Safety·Philip Gerretsen, Bruce G Pollock
Nov 20, 2013·Drug and Chemical Toxicology·Robert SobkowiakAndrzej Lesicki
May 25, 2012·Drug and Alcohol Dependence·Mehmet Sofuoglu, Mark G LeSage
Nov 24, 2011·Thoracic Surgery Clinics·Alberto de HoyosMalcolm M DeCamp
Oct 29, 2011·Clinics in Liver Disease·Andrea DiMartiniMary Amanda Dew
Feb 2, 2011·Pediatric Clinics of North America·Gabriel Kaplan, Iliyan Ivanov
Jun 14, 2012·Orthopedics·Abby M Bailey, Tracy Macaulay
Apr 27, 2013·The American Journal on Addictions·Kevin P HillShelly F Greenfield
Mar 16, 2013·British Journal of Clinical Pharmacology·Henri-Jean AubinIvan Berlin
Aug 27, 2015·Drug and Alcohol Dependence·Dustin C LeeCatherine Stanger
Apr 12, 2015·Neurochemical Research·Barbara BudzynskaGrazyna Biala
Jun 19, 2013·Substance Abuse : Research and Treatment·Kristin V CarsonBrian J Smith
Aug 28, 2020·Substance Abuse : Research and Treatment·Robert KagaboKolawole Okuyemi
Dec 30, 2020·Expert Opinion on Pharmacotherapy·Sabina Antonela AntoniuAntigona Carmen Trofor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.